EntryPoint Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
OHA
EntryPoint Capital's EBS Position: Q2 2026 in Review
EntryPoint Capital reduced its Emergent Biosolutions (EBS) stake by 29% in Q2 2026, selling an estimated $35K and leaving 10,390 shares worth $87.1K. The position accounts for 0.02% of the portfolio, ranked #751.
EntryPoint Capital first reported a position in EBS in Q3 2024 and has held it in 4 quarters since. The position peaked at $276K in Q2 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- EntryPoint Capital held 10,390 shares of Emergent Biosolutions worth $87.1K as of Q2 2026.
- EntryPoint Capital sold 4,187 Emergent Biosolutions shares in Q2 2026, an estimated $35K.
- Emergent Biosolutions made up 0.02% of EntryPoint Capital's portfolio in Q2 2026, its #751 holding.
- EntryPoint Capital first reported a position in Emergent Biosolutions in Q3 2024 and has held it in 4 quarters since.
- EntryPoint Capital's Emergent Biosolutions position peaked at $276K in Q2 2025.
- 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.